AU Patent

AU2006255559B2 — Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases

Assigned to Novartis AG · Expires 2009-12-17 · 16y expired

What this patent protects

The invention provides a pharmaceutical combination comprising: a) a pyrimidylaminobenzamide compound, and b) imatinib. and a method for treating or preventing a proliferative disease, especially GIST, using such a combination.

USPTO Abstract

The invention provides a pharmaceutical combination comprising: a) a pyrimidylaminobenzamide compound, and b) imatinib. and a method for treating or preventing a proliferative disease, especially GIST, using such a combination.

Drugs covered by this patent

Patent Metadata

Patent number
AU2006255559B2
Jurisdiction
AU
Classification
—
Expires
2009-12-17
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.